Dr Boon Cher Goh
Head of Department of Haematology-Oncology, Director of Investigational Medicine Unit was trained in Internal Medicine and Medical Oncology at the National University of Singapore, and was visiting fellow at the University of Chicago Section of Hematology-Oncology and Committee on Clinical Pharmacology. He has contributed much to the development of a clinical trial research infrastructure at the National University Health System, one of the largest clinical research groups in Singapore, and chaired the Cancer Therapeutics Research Group, an Asia Pacific cancer research group.
He has mentored many clinical oncology and pharmacology fellows, and has been awarded senior clinician scientist from the Biomedical Research Council and the National Medical Research Council since 2005. In addition, he has been competitive in research grants, having held several large government awarded research grants. His research achievements have been in investigating novel agents for treatment of cancer as well as pharmacogenomics of cancer drugs, and have extensively published in these areas. Internationally, he has served on advisory boards on several pharmaceutical companies in early drug development, and has served on editorial boards of important journals like the Journal of Clinical Oncology and Annals of Oncology. As a responsible member of clinical research, he has also espoused principles of ethics, and served for several terms as Chairman of the Domain Specific Research Board.
Currently he is Director of the Investigational Medicine Unit at the NUHS, and head of Hematology-Oncology, and Deputy Director of the Cancer Science Institute of Singapore.